Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

HANS BIOMED CORP Receives Approval from FDA


Thursday, 13 Jun 2013 10:54pm EDT 

HANS BIOMED CORP announced that it has received a 510K (medical equipment) approval from Food and Drug Administration on June 14, 2013 for its MINT LIFT (Minimal Invasive Non-Surgical Thread) product. The product's 510(K) number is K130191. 

Company Quote

13900.0
150.0 +1.09%
31 Jul 2014